Develops sublingual aspirin for heart attacks and strokes.
Jun 2026Revenue $97.7K/yrExpenses $7.42M/yr
No trendCash runway ≈ 1.7 years from Jun 2026
Figures by year
When will Aspire-Lakewood Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $97.7K and expenses $7.42M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $6.20K | $19.4M | −$19.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.